During the past decade, Carle Physician Group-Effingham conducted 198 clinical trials. In the 10-year time frame, 198 clinical trials started and 74 clinical trials were completed, i.e. on average, 37.4% percent of trials that started reached the finish line to date. In the past 5 years, 76 clinical trials started and 56 clinical trials were completed. i.e. 73.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carle Physician Group-Effingham" #1 sponsor was "National Cancer Institute (NCI)" with 123 trials, followed by "SWOG Cancer Research Network" with 42 trials sponsored, "Alliance for Clinical Trials in Oncology" with 38 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carle Physician Group-Effingham" #1 collaborator was "National Cancer Institute (NCI)" with 139 trials as a collaborator, "NRG Oncology" with 26 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Carle Physician Group-Effingham" are "Stage IV Lung Cancer AJCC v8" (12 trials), "Invasive Breast Carcinoma" (11 trials), "Recurrent Lung Non-Small Cell Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Metastatic Malignant Neoplasm in the Brain" (8 trials). Many other conditions were trialed in "Carle Physician Group-Effingham" in a lesser frequency.

Most popular intervention types in "Carle Physician Group-Effingham" are "Drug" (201 trials), "Other" (165 trials), "Biological" (112 trials), "Procedure" (86 trials) and "Radiation" (43 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (72 trials), "Laboratory Biomarker Analysis" (62 trials), "Questionnaire Administration" (53 trials), "Computed Tomography" (48 trials) and "Biospecimen Collection" (44 trials). Other intervention names were less common.

The vast majority of trials in "Carle Physician Group-Effingham" are 217 trials for "All" genders, 38 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Carle Physician Group-Effingham". undefined are not yet recruiting, 102 are recruiting, 117 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Carle Physician Group-Effingham, 6 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Carle Physician Group-Effingham, 7 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 124 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".